News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Zaderej Karen L.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/12/2023 |
4
| Zaderej Karen L. (Director) has filed a Form 4 on EyePoint Pharmaceuticals, Inc.|
Txns:
| Exercised 2,000 restricted stock units
@ $0 |
|
| 03/20/2023 |
4
| Zaderej Karen L. (CEO) has filed a Form 4 on Axogen, Inc.|
Txns:
| Exercised 25,000 restricted stock units
@ $0
Exercised 12,975 restricted stock units
@ $0
Granted 179,000 options to buy
@ $8.27, valued at
$1.5M
Granted 112,000 restricted stock units
@ $0 |
|
| 12/29/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/20/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/18/2022 |
4
| Zaderej Karen L. (CEO) has filed a Form 4 on Axogen, Inc.|
Txns:
| Exercised 25,950 restricted stock units
@ $0
Granted 169,694 restricted stock units
@ $0
Granted 317,185 options to buy
@ $0 |
|
| 02/17/2022 |
4
| Zaderej Karen L. (CEO) has filed a Form 4 on Axogen, Inc.|
Txns:
| Granted 13,978 shares
@ $0 |
|
| 12/29/2021 |
4
| Zaderej Karen L. (CEO) has filed a Form 4 on Axogen, Inc.|
Txns:
| Paid exercise price by delivering 1,752 shares
@ $9.74, valued at
$17.1k
Exercised 4,400 restricted stock units
@ $0 |
|
| 12/22/2021 |
4
| Zaderej Karen L. (CEO) has filed a Form 4 on Axogen, Inc.|
Txns:
| Paid exercise price by delivering 1,243 shares
@ $9.24, valued at
$11.5k
Exercised 3,125 restricted stock units
@ $0 |
|
| 11/29/2021 |
4
| Zaderej Karen L. (CEO) has filed a Form 4 on Axogen, Inc.|
Txns:
| Exercised 52,375 options to buy
@ $8.95, valued at
$468.8k
|
|
| 08/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/20/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/29/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/18/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/18/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/12/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/30/2020 |
4
| Zaderej Karen L. (CEO) has filed a Form 4 on Axogen, Inc.|
Txns:
| Granted 8,800 shares
@ $0
Sold 3,500 shares
@ $17.81, valued at
$62.3k
|
|
| 12/28/2020 |
4
| Zaderej Karen L. (CEO) has filed a Form 4 on Axogen, Inc.|
Txns:
| Exercised 19,375 options to buy
@ $4.81, valued at
$93.2k
|
|
| 12/22/2020 |
4
| Zaderej Karen L. (CEO) has filed a Form 4 on Axogen, Inc.|
Txns:
| Granted 3,125 shares
@ $0
Sold 1,275 shares
@ $16.42, valued at
$20.9k
|
|
| 11/10/2020 |
4
| Zaderej Karen L. (CEO) has filed a Form 4 on Axogen, Inc.|
Txns:
| Sold 14,000 shares
@ $14.53, valued at
$203.4k
|
|
| 04/20/2020 |
4
| Zaderej Karen L. (CEO) has filed a Form 4 on Axogen, Inc.|
Txns:
| Exercised 11,625 options to buy
@ $4.81, valued at
$55.9k
|
|
| 03/18/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/20/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/17/2020 |
4
| Zaderej Karen L. (CEO) has filed a Form 4 on Axogen, Inc.|
Txns:
| Granted 40,000 shares
@ $0
Disposed/sold 10,112 shares
@ $17.34, valued at
$175.3k
|
|
| 12/20/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/27/2019 |
4
| Zaderej Karen L. (Director) has filed a Form 4 on VIVEVE MEDICAL, INC.|
Txns:
| Granted 330,000 options to buy
@ $0.869, valued at
$286.8k
|
|
| 08/12/2019 |
4
| Zaderej Karen L. (CEO) has filed a Form 4 on Axogen, Inc.|
Txns:
| Bought 75,000 shares
@ $13.499, valued at
$1M
|
|
| 07/02/2019 |
4
| Zaderej Karen L. (Director) has filed a Form 4 on VIVEVE MEDICAL, INC.|
Txns:
| Granted 37,829 shares
@ $0 |
|
| 05/31/2019 |
4
| Zaderej Karen L. (Director) has filed a Form 4 on VIVEVE MEDICAL, INC.|
Txns:
| Granted 35,000 options to buy
@ $0.58, valued at
$20.3k
|
|
| 05/31/2019 |
4
| Zaderej Karen L. (CEO) has filed a Form 4 on Axogen, Inc.|
Txns:
| Exercised 18,056 options to buy
@ $0.27, valued at
$4.9k
|
|
| 04/03/2019 |
4
| Zaderej Karen L. (Director) has filed a Form 4 on VIVEVE MEDICAL, INC.|
Txns:
| Granted 14,248 shares
@ $0 |
|
|
|
|